MabCure, Inc. (OTCPK: MBCI)
Health Care · Biotechnology · US
$—
— today · — 1Y
MabCure, Inc. (OTCPK: MBCI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $11.72K and employs 3 people.
trading between 0.00 and 0.00.
Tweenvest scores MabCure, Inc. across four factors: quality 59/100, value 56/100. Its strongest factor is quality.
MBCI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.72K
- Revenue (TTM)
- $500.00K
- P/E
- —
- EPS
- -0.19
- Dividend yield
- —
- Beta (5Y)
- -25.17
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 781.09M
- Employees
- 3
- Next earnings
- —
About MabCure, Inc.
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
- ISIN
- US5540941029
- Founded
- 2006
- Listed since
- Dec 5, 2007
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vaxxinity, Inc.OTCPK: VAXX | $12.68K | $0.00 | -99.00% |
| NovAccess Global Inc.OTCPK: XSNX | $12.33K | $— | — |
| Scorpius Holdings, Inc.OTCPK: SCPX | $12.23K | $0.00 | -60.00% |
| ObsEva SAOTCPK: OBSE.F | $11.72K | $0.00 | +9900.00% |
| Trevena, Inc.OTCPK: TRVN | $11.51K | $0.01 | +7.14% |
| Syros Pharmaceuticals, Inc.OTCPK: SYRS | $10.73K | $0.00 | -96.67% |
| GeneLink, Inc.OTCPK: GNLK.Q | $10.60K | $— | — |
| Navidea Biopharmaceuticals, Inc.OTCPK: NAVB.Q | $10.00K | $0.00 | +9900.00% |
Figures last refreshed Oct 4, 2026.